Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy
NCT ID: NCT03933605
Last Updated: 2019-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2017-07-10
2019-02-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect on Anxiolytics With Type of Antiemetic Agents on Postoperative Nausea and Vomiting in High Risk Patients
NCT04466046
The Effect of Oral and Intravenous Ramosetron During Laparoscopic Cholecystectomy
NCT01041183
Post-operative Nausea Vomiting in Laparoscopic Cholecystectomy
NCT02803788
Continuous Infusion of Palonosetron for Preventing of Postoperative Nausea and Vomiting
NCT01482468
Effect of Remimazolam on Postoperative Nausea and Vomiting
NCT05439057
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
midazolam and palonosetron
0.05 mg/kg of midazolam i.v. with 0.075 mg of palonosetron i.v. was administered after anesthetic induction
midazolam and palonosetron group
intravenous midazolam and palonosetron administraion as prevention of postoperative nausea and vomiting
palonosetron
the same volume (0.05 mg/kg) of normal saline i.v. with 0.075 mg of palonosetron i.v. was administered after anesthetic induction
palonosetron group
intravenous palonosetron administraion as prevention of postoperative nausea and vomiting
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
midazolam and palonosetron group
intravenous midazolam and palonosetron administraion as prevention of postoperative nausea and vomiting
palonosetron group
intravenous palonosetron administraion as prevention of postoperative nausea and vomiting
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yeungnam University College of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eun Kyung Choi
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eun kyung Choi
Daegu, Korea (the Republic Of), South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
YUMC 2017-04-030
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.